Nathalia Souza, a 37-year-old from New Jersey, started taking tirzepatide after three years of dieting and exercising resulted in just 30 pounds of weight loss
Ongoing monitoring and support are crucial after discontinuing GLP-1 therapy
We have chosen to compliment our main business with logistics and technical support.
This is an oral medication in the sense that were used to an oral medication that we can just put it in our Monday, Tuesday, Wednesday, Thursday tray and take it with our other oral medications without regard to food or most worries about drug interactions or anything like that, Eli Lilly CEO Dave Ricks told me in an interview last week
So I stand by this statement: in my case, weight gain was driven by metabolic disruption
In practice, any observed weight change in people likely results from calorie displacement rather than GLP-1 appetite control